| Literature DB >> 11395202 |
K Okuda1, A Ihata, S Watabe, E Okada, T Yamakawa, K Hamajima, J Yang, N Ishii, M Nakazawa, K Okuda1, K Ohnari, K Nakajima, K Q Xin.
Abstract
DNA vaccination is characterized by its preferential induction of the cytotoxic T cell lymphocyte (CTL) response and is expected to be a useful means of protection against viral infection. We examined the protective effect of an expression plasmid (pME18S-M) containing M1 and M2 genes of influenza A/PR/8/34. We detected the CTL activity by introducing these plasmids into BALB/c mice by either the intramuscular or the intranasal route. The influenza-specific antibody response was also induced, although its neutralizing effect against influenza virus was not observed. From 70 to 80% protection was observed in the mice immunized with the pME18S-M plasmid followed by lethal infection with influenza viruses of the A/WSN/33 and A/PR/8/34 strains, whereas all mice without the plasmid vaccination failed to survive. This protective activity was significantly weakened when the CD8(+) cells of these immunized mice were eliminated by several injections of anti-CD8 antibody. The protective activity was also weakened when anti-CD4 antibody was injected in the early phase of DNA vaccination. These data suggest that the pME18S-M plasmid is useful as a DNA vaccine for overcoming highly mutational influenza viruses.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11395202 DOI: 10.1016/s0264-410x(01)00078-0
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641